Archived documents

Documents past their public comment period for Healthcare & Public Health.

DEANotice

2026-12144

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 18
DEANotice

2026-11911

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
DEANotice

2026-13145

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 31
DEANotice

2026-13144

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 31
DEANotice

2026-13164

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →Closes Jul 31
FAANotice

Petition for Exemption; Summary: Wings of Mercy, Inc.

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDANotice

Pediatric Dosing with Over-the-Counter Drug Products; Summary Information Document for Advisory Committee Meeting; Availability; Establishment of a Public Docket and Request for Comments

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDANotice

Determination That SERZONE (Nefazodone Hydrochloride) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness", also download published version into the folder.

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDANotice

Determination That DIAZEPAM Injection United States Pharmacopeia (5 Milligrams/Milliliter in a 1- Milliliter Container) Was not Withdrawn From Sale for Reasons of Safety or Effectiveness

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDANotice

Determination That PYRIDOSTIGMINE BROMIDE Tablets, 30 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOther

Letter from FDA CDER to Lachman Consultant Services, Inc.

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDANotice

"Determination That LOVENOX (Enoxaparin Sodium) 90 Milligrams/0.6 Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →